Latka logo
Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.revenue & market cap

Salt Lake City, UtahFounded 2013

Public company

Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures, and markets state-of-the-art diagnostics technologies.

co-dx.comLinkedInUpdated Sep 28, 2026
Annual revenue
$622.5K
Dec 2025 · Stock Analysis−84% YoY
Market cap
$6.9M
Sep 2026

Co-Diagnostics, Inc. revenue

Co-Diagnostics, Inc.'s annual revenue was $622.5K in December 2025 (Stock Analysis). That is down 84% from $3.9M a year earlier.

$0
$1M
$2M
$3M
$0
–
$3.9M
$622.5K
20132014–2320242025
ReportedFounded 2013 at $0; every reading has its own bar
All 2 revenue readings, with sources
As ofRevenueSource
Dec 2024$3.9MStock Analysis
Dec 2025$622.5KStock Analysis

Co-Diagnostics, Inc. market cap

Co-Diagnostics, Inc. is a public company. Its market capitalisation was $6.9M in September 2026.

Co-Diagnostics, Inc. FAQ

What is Co-Diagnostics, Inc.'s revenue?

Co-Diagnostics, Inc.'s annual revenue was $622.5K in December 2025, according to Stock Analysis.

Is Co-Diagnostics, Inc. publicly traded?

Yes. Co-Diagnostics, Inc. is a public company, with a market capitalisation of $6.9M in September 2026.

Categories

How this page is sourced

2 from public sources. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 28, 2026Data disclaimerReport a correctionClaim this profileRun Co-Diagnostics, Inc.? Join the podcast